We undertook a prospective cohort investigation of the association between CYP2A6 genotype and smoking cessation, defined here as smoking abstinence for ≥12 months, in a cohort of Caucasian adolescent smokers. We hypothesized that being a CYP2A6 slow nicotine metabolizer is associated with an increased likelihood of smoking cessation.
